Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy

• Published in: Cellular oncology (Dordrecht) Vol. 47; no. 2; pp. 415 - 428
• Main Authors: Li, Liang, Ma, Si-Rui, Yu, Zi-Li
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.04.2024; Springer Nature B.V
• Subjects: Animals; Biomedical and Life Sciences; Biomedicine; Cancer immunotherapy; Cancer Research; Cancer therapies; Drug delivery; Humans; Immunotherapy; Immunotherapy - methods; Lipid Metabolism; Lipid peroxidation; Lipids; Lipolysis; Macrophages; Metabolic disorders; Metabolic Reprogramming; Metabolism; Neoplasms - immunology; Neoplasms - metabolism; Neoplasms - therapy; Oncology; Pathology; Phenotypes; Review; Solid tumors; Tumor Microenvironment - immunology; Tumor-Associated Macrophages - immunology; Tumor-Associated Macrophages - metabolism; Tumorigenesis; Immunometabolism; Lipid metabolism; Tumor microenvironment; Cancer immunotherapy; Tumor-associated macrophages
• ISSN: 2211-3428; 2211-3436
• DOI: 10.1007/s13402-023-00881-y

Background Tumor-associated macrophages, as the major immunocytes in solid tumors, show divided loyalty and remarkable plasticity in tumorigenesis. Once the M2-to-M1 repolarization is achieved, they could be switched from the supporters for tumor development into the guardians for host immunity. Meanwhile, Lipid metabolic reprogramming is demonstrated to be one of the most important hallmarks of tumor-associated macrophages, which plays a decisive role in regulating their phenotypes and functions to promote tumorigenesis and immunotherapy resistance. Therefore, targeting the lipid metabolism of TAMs may provide a new direction for anti-tumor strategies. Conclusion In this review, we first summarized the origins, classifications and general lipid metabolic process of TAMs. Then we discussed the currently available drugs and interventions that target lipid metabolic disorders of TAMs, including those targeting lipid uptake, efflux, lipolysis, FAO and lipid peroxidation. Besides, based on the recent research status, we summarized the present challenges for this cancer immunotherapy, including the precise drug delivery system, the lipid metabolic heterogeneity, and the intricate lipid metabolic interactions in the TME, and we also proposed corresponding possible solutions. Collectively, we hope this review will give researchers a better understanding of the lipid metabolism of TAMs and lead to the development of corresponding anti-tumor therapies in the future.